Showing results (1031-1040 of 1,084) with videos related to
Sort By:
Pageof 109
ACS Infectious Diseases|August 14, 2024
The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparumSavannah J Watson, Mariëtte E van der Watt, Anjo Theron, et al.Journal of Medicinal Chemistry|October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial ImidazopyridazinesClaire Le Manach, Tanya Paquet, Christel Brunschwig, et al.Nature|July 3, 2025
Mapping the adaptive landscape of Batesian mimicry using 3D-printed stimuliChristopher H Taylor, David James George Watson, John Skelhorn, et al.Plos Genetics|March 18, 2015
Exome sequencing in an admixed isolated population indicates NFXL1 variants confer a risk for specific language impairmentPía Villanueva, Ron Nudel, Alexander Hoischen, et al.Plos One|February 1, 2017
Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus MacaquesLark L Coffey, Patricia A Pesavento, Rebekah I Keesler, et al.Oncotarget|August 22, 2015
The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eµ-MYC driven B-cell lymphomaMike I Walton, Paul D Eve, Angela Hayes, et al.Cell Reports|October 27, 2021
Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammationAnil Verma, Chase E Hawes, Yashavanth Shaan Lakshmanappa, et al.Journal of Medicinal Chemistry|October 26, 2020
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In Vivo Efficacy in the Plasmodium falciparum NSG Mouse ModelAndré Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.Frontiers in Immunology|December 23, 2021
Rhesus Macaque CODEX Multiplexed Immunohistochemistry Panel for Studying Immune Responses During Ebola InfectionSizun Jiang, Nilanjan Mukherjee, Richard S Bennett, et al.Journal of Medicinal Chemistry|February 17, 2006
Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxietyMichael G N Russell, Robert W Carling, Leslie J Street, et al.Pageof 109